Davis's Drug Guide
lyme disease vaccine (recombinant OspA)
General
**Off Market Drug**
This medication is no longer available in the United States. Information provided here is for reference purposes only.
Pronunciation:
lime diz-eez vak-seen
Trade Name(s)
- LYMErix
Ther. Class.
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., et al. "Lyme Disease Vaccine (recombinant OspA)." Davis's Drug Guide, 18th ed., F.A. Davis Company, 2023. www.drugguide.com/ddo/view/Davis-Drug-Guide/109125/all/lyme_disease_vaccine__recombinant_OspA_.
Vallerand AHA, Sanoski CAC, Quiring CC. Lyme disease vaccine (recombinant OspA). Davis's Drug Guide. F.A. Davis Company; 2023. https://www.drugguide.com/ddo/view/Davis-Drug-Guide/109125/all/lyme_disease_vaccine__recombinant_OspA_. Accessed December 2, 2023.
Vallerand, A. H., Sanoski, C. A., & Quiring, C. (2023). Lyme disease vaccine (recombinant OspA). In Davis's Drug Guide (18th ed.). F.A. Davis Company. https://www.drugguide.com/ddo/view/Davis-Drug-Guide/109125/all/lyme_disease_vaccine__recombinant_OspA_
Vallerand AHA, Sanoski CAC, Quiring CC. Lyme Disease Vaccine (recombinant OspA) [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2023. [cited 2023 December 02]. Available from: https://www.drugguide.com/ddo/view/Davis-Drug-Guide/109125/all/lyme_disease_vaccine__recombinant_OspA_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - lyme disease vaccine (recombinant OspA)
ID - 109125
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
AU - Quiring,Courtney,
BT - Davis's Drug Guide
UR - https://www.drugguide.com/ddo/view/Davis-Drug-Guide/109125/all/lyme_disease_vaccine__recombinant_OspA_
PB - F.A. Davis Company
ET - 18
DB - Davis's Drug Guide
DP - Unbound Medicine
ER -